ACADIA Pharmaceuticals's total assets for Q1 2026 were $1.61B, an increase of 2.62% from the previous quarter. ACAD total liabilities were $357.16M for the fiscal quarter, a 6.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.